About us
The InnoSIGN team is committed to transform cancer care by enabling personalized targeted therapy options through OncoSIGNal pathway activity profiling. Our team has a wealth of experience in bringing innovative diagnostic solutions to the market.
revolutionizing precision medicine
Board of Directors
Meet the team
Eric Lindquist
Chief Executive OfficerPaul van de Wiel
Chief Operating OfficerSigi Neerken
Chief Business OfficerEveline den Biezen
Chief Scientific OfficerAnke Pierik
Chief Technology OfficerRobert Babkowski MD
CLIA Lab Medical DirectorAnne van Brussel
Application ScientistSandra Gunselman
Director CLIA Lab OperationsLaurent Holtzer
Solutions ArchitectDiederick Keizer
Clinical Operation Manager![](https://www.innosignbio.com/wp-content/uploads/2024/05/Headshot-Professional-1-3-241x0-c-default.jpeg)